Studies have shown that miRNAs target VDR in breast carcinoma and liver fibrosis and then affect disease progression (Liu X. et al., 2018; He et al., 2021), but whether these miRNAs are differentially expressed in TB is still unclear. This evidence concerns the gene VDR and breast carcinoma.